Literature DB >> 11292469

The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study.

N R Dunn1, A Arscott, M Thorogood.   

Abstract

To examine the relationship between use of oral contraceptives and the risk of dying from myocardial infarction, we made a comparison of deceased patients and live patients (women aged less than 45) identified for the Myocardial Infarction Causality case-control study, using data obtained from general practice medical notes. There were 422 live patients and 110 deceased patients of women with a myocardial infarction with data available. The adjusted odds ratio for exposure to second generation oral contraceptives and risk of death within 28 days of a myocardial infarction compared with no oral contraceptive use was raised (2.88, 95% confidence interval 1.22-6.77), and this effect was not seen for other types of oral contraceptives including third generation oral contraceptive formulations. In absolute terms, between 47,000 and 71,000 women would have to be exposed to a second generation pill for one year to result in one extra death from myocardial infarction, and this risk applies mainly to smokers. The results suggest a slightly increased relative risk of death among those having a myocardial infarction associated with exposure to second generation oral contraceptives, but this represents a small absolute risk. Further work is required before any change in contraceptive practice should be advocated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292469     DOI: 10.1016/s0010-7824(01)00172-x

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

1.  Explanation and Elaboration Document for the STROBE-Vet Statement: Strengthening the Reporting of Observational Studies in Epidemiology-Veterinary Extension.

Authors:  A M O'Connor; J M Sargeant; I R Dohoo; H N Erb; M Cevallos; M Egger; A K Ersbøll; S W Martin; L R Nielsen; D L Pearl; D U Pfeiffer; J Sanchez; M E Torrence; H Vigre; C Waldner; M P Ward
Journal:  J Vet Intern Med       Date:  2016-11-07       Impact factor: 3.333

Review 2.  Contraceptive hormone use and cardiovascular disease.

Authors:  Chrisandra L Shufelt; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

Review 3.  Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.

Authors:  Omosalewa O Lalude
Journal:  Curr Cardiol Rep       Date:  2013-07       Impact factor: 2.931

4.  Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.

Authors:  Alain Weill; Marie Dalichampt; Fanny Raguideau; Philippe Ricordeau; Pierre-Olivier Blotière; Jérémie Rudant; François Alla; Mahmoud Zureik
Journal:  BMJ       Date:  2016-05-10

Review 5.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.